• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Brainstorm Cell Therapeutics Inc

+ Add to Watchlist

BCLI:US

3.8500 USD 0.00000.00%

As of 20:10:00 ET on 12/26/2014.

Snapshot for Brainstorm Cell Therapeutics Inc (BCLI)

Open: 3.9900 Day's Range: 3.7900 - 4.1800 Volume: 264,449
Previous Close: 3.8500 52wk Range: 2.0250 - 5.7000 1-Yr Rtn: +80.75%

Stock Chart for BCLI

No chart data available.
  • BCLI:US 3.8500
  • 1D
  • 1M
  • 1Y
3.8500
Interactive BCLI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BCLI

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -0.0300
Est. PEG Ratio -
Market Cap (M USD) 58.83
Shares Outstanding (M) 15.28
30 Day Average Volume 85,445
Price/Book (mrq) 6.5867
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BCLI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BCLI

Brainstorm Cell Therapeutics Inc is a biotechnology company developing autologous adult stem cell therapies for neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS) , also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD).

Anthony Fiorino "Tony"Chief Executive OfficerChaim LebovitsPresident
Liat SossoverChief Financial OfficerUri YablonkaChief Operating Officer
More Company Profile & Key Executives for BCLI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil